Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Gallardo, A; Matias-Guiu, X; Lagarda, H; Catasus, L; Bussaglia, E; Gras, E; Suarez, D; Prat, J

    Malignant mullerian mixed tumor arising from ovarian serous carcinoma: a clinicopathologic and molecular study of two cases

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 21 268-272. .

    [doi:10.1097/00004347-200207000-00010]

  • Sabate, JM; Gomez, A; Torrubia, S; Matias-Guiu, X; Alonso, C; Pericay, C; Diaz, O

    Microglandular adenosis of the breast in a BRCa1 mutation carrier: radiological features

    EUR RADIOL 12 1479-1482. .

    [doi:10.1007/s00330-001-1174-4]

  • Llauger, J; Bague, S; Palmer, J; Matias-Guiu, X; San Roman, L; Doncel, A

    Focal myositis of the thigh: unusual MR pattern

    SKELETAL RADIOL 31 307-310. .

    [doi:10.1007/s00256-002-0494-z]

  • Bussaglia, E; Pujol, RM; Gil, MJ; Marti, RM; Tuneu, A; Febrer, MI; Garcia-Patos, V; Ruiz, EM; Barnadas, M; Alegre, M; Serrano, S; Matias-Guiu, X

    PTEN mutations in eight Spanish families and one Brazilian family with Cowden syndrome.

    JOURNAL OF INVESTIGATIVE DERMATOLOGY 118 639-644. .

    [doi:10.1046/j.1523-1747.2002.01728.x]

  • Muret, MPG; Puig, L; Pujol, RM; Matias-Guiu, X; Alomar, A

    Non-congenital smooth muscle hamartoma: 3 cases

    ANN DERMATOL VENER 129 417-420. .

  • Machin, P; Catasus, L; Pons, C; Munoz, J; Matias-Guiu, X; Prat, J

    CTNNB1 mutations and beta-catenin expression in endometrial carcinomas

    HUMAN PATHOLOGY 33 206-212. .

    [doi:10.1053/hupa.2002.30723]

  • Gras, E; Catasus, L; Arguelles, R; Moreno-Bueno, G; Palacios, J; Gamallo, C; Matias-Guiu, X; Prat, J

    Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors

    CANCER 92 2829-2836. .

    [doi:10.1002/1097-0142(20011201)92:11<2829::AID-CNCR10094>3.0.CO;2-3]

  • Matias-Guiu, X; Prat, J

    Tumor invasion and metastasis - Nature or nurture? Reply

    HUMAN PATHOLOGY 32 1416-1416. .

    [doi:10.1053/hupa.2001.29637]

  • Rodriguez, I; Ayala, E; Caballero, C; De Miguel, C; Matias-Guiu, X; Cubilla, AL; Rosai, J

    Solitary fibrous tumor of the thyroid gland - Report of seven cases

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 25 1424-1428. .

    [doi:10.1097/00000478-200111000-00011]

  • Domingo, P; Matias-Guiu, X; Pujol, RM; Domingo, JC; Arroyo, JA; Sambeat, MA; Vazquez, G

    Switching to nevirapine decreases insulin levels but does not improve subcutaneous adipocyte apoptosis in patients with highly active antiretroviral therapy-associated lipodystrophy

    JOURNAL OF INFECTIOUS DISEASES 184 1197-1201. .

    [doi:10.1086/323805]

  • Gras, E; Pons, C; Machin, P; Matias-Guiu, X; Prat, J

    Loss of heterozygosity at the RB-1 locus and pRB immunostaining in epithelial ovarian tumors: a molecular, immunohistochemical, and clinicopathologic study

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 20 335-340. .

    [doi:10.1097/00004347-200110000-00004]

  • Gras, E; Cortes, J; Diez, O; Alonso, C; Matias-Guiu, X; Baiget, M; Prat, J

    Loss of heterozygosity on chromosome 13q12-q14, BRCa-2 mutations and lack of BRCa-2 promoter hypermethylation in sporadic epithelial ovarian tumors

    CANCER 92 787-795. .

    [doi:10.1002/1097-0142(20010815)92:4<787::AID-CNCR1384>3.0.CO;2-4]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU